Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003). (7th October 2003)

• Record Type: Journal Article
• Authors: Furst, D E; Breedveld, F C; Kalden, J R; Smolen, J S; Burmester, G R; Dougados, M; Emery, P; Gibofsky, A; Kavenaugh, A F; Keystone, E C; Klareskog, L; Russell, A S; van de Putte, L B A; Weisman, M H
• Is Part Of: Annals of the rheumatic diseases. Volume 62(2003)Supplement 2
• Page Start: ii2
• Page End: ii9
• Publication Date: 2003-10-07
• Subjects: consensus statement -- biological agents -- rheumatoid arthritis; aCL, anticardiolipin antibodies -- ACR, American College of Rheumatology -- ANA, antinuclear antibodies -- CHF, congestive heart failure -- DAS, disease activity score -- DMARD, disease modifying antirheumatic drug -- HAQ-DI, Health Assessment Questionnaire disability index -- IL, interleukin -- IL1Ra, IL1 receptor antagonist -- MTX, methotrexate -- RA, rheumatoid arthritis -- TNF, tumour necrosis factor -- VAS, visual analogue scale; Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/ard.62.suppl_2.ii2
• Languages: English
• ISSNs: 0003-4967